ReviewJournal of Korean medical science2019
The Korean National Burden of Disease Study: from Evidence to Policy.
Review in Journal of Korean medical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Healthy Life Expectancy at Birth as the Target Indicator of National Health Strategy.Journal of Korean medical science · 2024Article
- Article
- Burden of Cancer Due to Cigarette Smoking and Alcohol Consumption in Korea.International journal of environmental research and public health · 2022Article
- Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies.Frontiers in public health · 2022Review
- Multimorbidity adjusted years lost to disability rates calculated through Monte-Carlo simulation in Korea.Epidemiology and health · 2022Article
- Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada.PLOS global public health · 2022Article
- Reflections on key methodological decisions in national burden of disease assessments.Archives of public health = Archives belges de sante publique · 2020Article
- Subnational Burden of Disease According to the Sociodemographic Index in South Korea.International journal of environmental research and public health · 2020Article
- The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years.Journal of Korean medical science · 2020Article
- Letter to the Editor: Chronic Kidney Disease - a Neglected Disease in the Economic Conditions Burden Analysis in Korea.Journal of Korean medical science · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), disability-adjusted life years (DALYs) have been widely used as a summary measure of population health. The DALY metric is a comprehensive measurement of population health, enabling comparison among groups. However, the available data and reliance on estimates to supplement the data gap require contextualization at the national level, and the outcomes of which are more appropriate for national policymakers. The Korean National Burden of Disease (KNBD) study was initiated by the Research and Development Project of the Ministry of Health and Welfare, funded by a 5-year grant from 2013, to contextualize the GBD method to the Korean population. Here, we provide a comprehensive overview of the KNBD study with its achievements and challenges and discuss the implications for public health policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.